A new fibrinolytic agent, BRL 26921, a member of the novel class of thrombolytic agents; the acyl enzymes, has been compared with streptokinase. It has been shown that this new agent, which can bind to fibrin before releasing activator, does not result in clinically significant destruction of the haemostatic system when compared to an equivalent dose of streptokinase.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF00607082 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!